Evidence map›Paper›PMID 27705249›Full record

ArticleThe New England journal of medicine2016

Life Expectancy after Myocardial Infarction, According to Hospital Performance.

Emily M Bucholz, Neel M Butala, Shuangge Ma, Sharon-Lise T Normand, Harlan M Krumholz

Abstract read
In one paragraph

Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Arquivos brasileiros de cardiologia · 2017
    Guideline
  2. Guideline
  3. Observational
  4. Observational
  5. Article
  6. Article
  7. Timing and treatment strategies according to SCAI classification in cardiogenic shock.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily M BucholzFrom the Department of Medicine, Boston Children's Hospital (E.M.B.), the Department of Internal Medicine, Massachusetts General Hospital (N.M.B.), the Department of Health Care Policy, Harvard Medical School (S.-L.T.N.), and the Department of Biostatistics, Harvard T.H. Chan School of Public Health (S.-L.T.N.) - all in Boston; and the Departments of Biostatistics (S.M.) and Health Policy and Management (H.M.K.), Yale School of Public Health, the Section of Cardiovascular Medicine, Department of Internal Medicine, and Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine (H.M.K.), and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.) - all in New Haven, CT.
Neel M ButalaFrom the Department of Medicine, Boston Children's Hospital (E.M.B.), the Department of Internal Medicine, Massachusetts General Hospital (N.M.B.), the Department of Health Care Policy, Harvard Medical School (S.-L.T.N.), and the Department of Biostatistics, Harvard T.H. Chan School of Public Health (S.-L.T.N.) - all in Boston; and the Departments of Biostatistics (S.M.) and Health Policy and Management (H.M.K.), Yale School of Public Health, the Section of Cardiovascular Medicine, Department of Internal Medicine, and Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine (H.M.K.), and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.) - all in New Haven, CT.
Shuangge MaFrom the Department of Medicine, Boston Children's Hospital (E.M.B.), the Department of Internal Medicine, Massachusetts General Hospital (N.M.B.), the Department of Health Care Policy, Harvard Medical School (S.-L.T.N.), and the Department of Biostatistics, Harvard T.H. Chan School of Public Health (S.-L.T.N.) - all in Boston; and the Departments of Biostatistics (S.M.) and Health Policy and Management (H.M.K.), Yale School of Public Health, the Section of Cardiovascular Medicine, Department of Internal Medicine, and Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine (H.M.K.), and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.) - all in New Haven, CT.
Sharon-Lise T NormandFrom the Department of Medicine, Boston Children's Hospital (E.M.B.), the Department of Internal Medicine, Massachusetts General Hospital (N.M.B.), the Department of Health Care Policy, Harvard Medical School (S.-L.T.N.), and the Department of Biostatistics, Harvard T.H. Chan School of Public Health (S.-L.T.N.) - all in Boston; and the Departments of Biostatistics (S.M.) and Health Policy and Management (H.M.K.), Yale School of Public Health, the Section of Cardiovascular Medicine, Department of Internal Medicine, and Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine (H.M.K.), and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.) - all in New Haven, CT.
Harlan M KrumholzFrom the Department of Medicine, Boston Children's Hospital (E.M.B.), the Department of Internal Medicine, Massachusetts General Hospital (N.M.B.), the Department of Health Care Policy, Harvard Medical School (S.-L.T.N.), and the Department of Biostatistics, Harvard T.H. Chan School of Public Health (S.-L.T.N.) - all in Boston; and the Departments of Biostatistics (S.M.) and Health Policy and Management (H.M.K.), Yale School of Public Health, the Section of Cardiovascular Medicine, Department of Internal Medicine, and Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine (H.M.K.), and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital (H.M.K.) - all in New Haven, CT.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Center for Cardiovascular Outcomes Research at Yale UniversityU01HL105270 · NHLBI · YALE UNIVERSITY · PI CURTIS, JEPTHA PELHAM, KRUMHOLZ, HARLAN MARC · 2010 to 2013
$5.8M
Long-term outcomes and life expectancy after acute myocardial infarctionF30HL120498 · NHLBI · YALE UNIVERSITY · PI BUCHOLZ, EMILY MARIE · 2014 to 2014
$40k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS F30 HL120498NHLBI NIH HHS U01 HL105270NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

backgroundThirty-day risk-standardized mortality rates after acute myocardial infarction are commonly used to evaluate and compare hospital performance. However, it is not known whether differences among hospitals in the early survival of patients with acute myocardial infarction are associated with differences in long-term survival.

methodsWe analyzed data from the Cooperative Cardiovascular Project, a study of Medicare beneficiaries who were hospitalized for acute myocardial infarction between 1994 and 1996 and who had 17 years of follow-up. We grouped hospitals into five strata that were based on case-mix severity. Within each case-mix stratum, we compared life expectancy among patients admitted to high-performing hospitals with life expectancy among patients admitted to low-performing hospitals. Hospital performance was defined by quintiles of 30-day risk-standardized mortality rates. Cox proportional-hazards models were used to calculate life expectancy.

resultsThe study sample included 119,735 patients with acute myocardial infarction who were admitted to 1824 hospitals. Within each case-mix stratum, survival curves of the patients admitted to hospitals in each risk-standardized mortality rate quintile separated within the first 30 days and then remained parallel over 17 years of follow-up. Estimated life expectancy declined as hospital risk-standardized mortality rate quintile increased. On average, patients treated at high-performing hospitals lived between 0.74 and 1.14 years longer, depending on hospital case mix, than patients treated at low-performing hospitals. When 30-day survivors were examined separately, there was no significant difference in unadjusted or adjusted life expectancy across hospital risk-standardized mortality rate quintiles.

conclusionsIn this study, patients admitted to high-performing hospitals after acute myocardial infarction had longer life expectancies than patients treated in low-performing hospitals. This survival benefit occurred in the first 30 days and persisted over the long term. (Funded by the National Heart, Lung, and Blood Institute and the National Institute of General Medical Sciences Medical Scientist Training Program.).

Indexed as

Life ExpectancyAgedAged, 80 and overFemaleFollow-Up StudiesHospitalsHumansMaleMyocardial InfarctionQuality of Health CareSurvival AnalysisUnited States

Identifiers

PMID27705249
PMCPMC5118048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.